Drug Giant Eli Lilly Shuns Subsidised Medication Listing, Citing Unfair Price
Eli Lilly refused to list its diabetes drug Mounjaro on Australia's PBS because the government's offered price was too low. This affects 450,000 Australians with Type 2 diabetes.
#EliLilly, #Mounjaro, #DiabetesAustralia, #PBS, #DrugPricing
https://newsletter.tf/eli-lilly-refuses-mounjaro-pbs-listing-australia/

